share_log

The Total Return for Mingchen HealthLtd (SZSE:002919) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years

The Total Return for Mingchen HealthLtd (SZSE:002919) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years

在过去五年中,明晨健康有限公司(深圳证券交易所:002919)投资者的总回报增长速度快于收益增长
Simply Wall St ·  05/25 22:42

Mingchen Health Co.,Ltd. (SZSE:002919) shareholders might be concerned after seeing the share price drop 25% in the last quarter. On the bright side the returns have been quite good over the last half decade. It has returned a market beating 81% in that time. While the long term returns are impressive, we do have some sympathy for those who bought more recently, given the 45% drop, in the last year.

明晨健康有限公司, Ltd.(深圳证券交易所:002919)股东在看到上个季度股价下跌了25%后可能会感到担忧。好的一面是,在过去的五年中,回报率一直相当不错。在此期间,它的市场回报率已超过81%。尽管长期回报令人印象深刻,但鉴于去年下降了45%,我们对最近买入的人有些同情。

In light of the stock dropping 10% in the past week, we want to investigate the longer term story, and see if fundamentals have been the driver of the company's positive five-year return.

鉴于该股在过去一周下跌了10%,我们想调查长期情况,看看基本面是否是该公司五年正回报率的驱动力。

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

在他的文章中 格雷厄姆和多兹维尔的超级投资者 沃伦·巴菲特描述了股价如何并不总是合理地反映企业的价值。研究市场情绪如何随着时间的推移而变化的一种方法是研究公司股价与其每股收益(EPS)之间的相互作用。

Over half a decade, Mingchen HealthLtd managed to grow its earnings per share at 23% a year. This EPS growth is higher than the 13% average annual increase in the share price. So it seems the market isn't so enthusiastic about the stock these days.

在过去的五年中,明晨健康有限公司设法将其每股收益增长到每年23%。每股收益的增长高于股价年均增长13%。因此,如今市场似乎对该股并不那么热情。

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

你可以在下面看到 EPS 是如何随着时间的推移而变化的(点击图片发现确切的值)。

earnings-per-share-growth
SZSE:002919 Earnings Per Share Growth May 26th 2024
SZSE: 002919 每股收益增长 2024 年 5 月 26 日

Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here.

在买入或卖出股票之前,我们始终建议仔细研究历史增长趋势,可在此处查阅。

What About The Total Shareholder Return (TSR)?

那么股东总回报(TSR)呢?

We've already covered Mingchen HealthLtd's share price action, but we should also mention its total shareholder return (TSR). The TSR attempts to capture the value of dividends (as if they were reinvested) as well as any spin-offs or discounted capital raisings offered to shareholders. Mingchen HealthLtd's TSR of 86% for the 5 years exceeded its share price return, because it has paid dividends.

我们已经报道了明晨健康有限公司的股价走势,但我们还应该提及其股东总回报率(TSR)。股东总回报率试图捕捉股息(就好像它们被再投资一样)以及向股东提供的任何分拆或折扣资本筹集的价值。明晨健康有限公司5年来的股东总回报率为86%,超过了其股价回报率,因为它已经派发了股息。

A Different Perspective

不同的视角

While the broader market lost about 10% in the twelve months, Mingchen HealthLtd shareholders did even worse, losing 45%. However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. On the bright side, long term shareholders have made money, with a gain of 13% per year over half a decade. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. Before forming an opinion on Mingchen HealthLtd you might want to consider these 3 valuation metrics.

尽管整个市场在十二个月中下跌了约10%,但明晨健康有限公司股东的表现甚至更糟,下跌了45%。但是,可能只是股价受到了更广泛的市场紧张情绪的影响。如果有很好的机会,可能值得关注基本面。好的一面是,长期股东赚了钱,在过去的五年中,每年增长13%。如果基本面数据继续显示长期可持续增长,那么当前的抛售可能是一个值得考虑的机会。在对Mingchen HealthLtd发表意见之前,你可能需要考虑这三个估值指标。

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: many of them are unnoticed AND have attractive valuation).

如果你想和管理层一起购买股票,那么你可能会喜欢这份免费的公司清单。(提示:其中许多未被注意且估值诱人)。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

请注意,本文引用的市场回报反映了目前在中国交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发